Biochemical study on immunomodulation and safety margin of inosine acedoben dimepranol before and after vaccination

Maksoud Hussein Abdel; Mahmoud Omnia; Khalifa Mahmoud

doi:10.30574/gscarr.2019.1.1.0008

Authors

Maksoud Hussein Abdel Department of Biochemistry, Benha University, Egypt.
Mahmoud Omnia Department of Biochemistry, Benha University, Egypt.
Khalifa Mahmoud Department of Biochemistry, Benha University, Egypt.

DOI:

https://doi.org/10.30574/gscarr.2019.1.1.0008

Keywords:

IAD, ND vaccine, Safety Profile

Abstract

The aim of this study was to evaluate the immunopotentiating effect of IAD in broiler chickens either vaccinated or unvaccinated and to evaluate the safety profile of IAD after treatment with escalating doses. To assess the immunological effect of IAD, eighty chicks were used and divided into four groups. First group kept as control group, second received Isoprinosine (16.3 mg/kg, day after day), third received a routine New Castle disease virus vaccine and the last group received both treatments of Isoprinosine and ND vaccine. The second part of the study aimed to evaluate the safety profile of IAD, to achieve this aim eighty chicks were used, divided equally and given different concentration of IAD 8.15, 16.3, 32.6 mg/kg day after day repetitively. We concluded that, IAD enhanced both nonspecific and specific immune responses in broiler chicken, especially in vaccinated ones, in terms of increased antibody and decreased NDV titers, indicated by HI and PCR, respectively. Also, IAD showed dose-dependent good safety profile, including blood picture, organ function profile and metabolic parameters, indicated by biochemical analyses.

Metrics

Metrics Loading ...

References

Schwabenbauer K and Rushton J. (2007).Veterinary services for poultry production. In Proceedings of the International Conference Poultry in the Twenty-first Century: avian influenza and beyond, held, 5-7.

Njei B, Garg SK, Kenta-Bibi E, Zhao P and Kongnyuy EJ. (2013). Isoprinosine versus other antiviral drugs for chronic hepatitis B. status and date: New, published in (4).

Apriasari ML. (2016). Methisoprinol as an immunomodulator for treating infectious mononucleosis. Dental Journal (Majalah Kedokteran Gigi) 49(1), 1-4.

Georgala S, Katoulis AC, Befon A, Georgala K and Stavropoulos PG. (2006). Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study. Acta dermato-venereologica, 86(5), 422-424.

Thomas JA and Thomas MJ. (1993).New biologics: their development, safety, and efficacy. In Biotechnology and safety assessment, 1-22, Raven Press New York.

Paget G and Barnes J. (1964). Evaluation of results: quantitative application in different species. Evaluation of drug activities: pharmacometrics 1, 161.

Ewopharma International L. (2002). ISOPRINOSINE® Inosine Acedoben Dimepranol, Argentina: unpublished.

Stenzel T, Tykałowski B, Śmiałek M, Kwiatkowska-Stenzel A and Koncicki A. (2011). 'The effect of different doses of methisoprinol on the percentage of CD4+ and CD8+ T lymphocyte subpopulation and the antibody titers in pigeons immunised against PPMV-1', Polish journal of veterinary sciences, 14(3), 367-371.

Petrova M, Jelev D, Ivanova A and Krastev Z. (2010). 'Isoprinosine affects serum cytokine levels in healthy adults', Journal of Interferon & Cytokine Research, 30(4), 223-228.

Ohnishi H, Kosuzume H, Inaba H, Ohkura M, Shimada S and Suzuki Y. (1983). 'The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections', International journal of immunopharmacology, 5(3), 181-196.

Wybran J, Govaerts A and Appelboom T. (1978). 'Inosiplex, a stimulating agent for normal human T cells and human leukocytes', The Journal of Immunology, 121(3), 1184-1187.

Waldman RH and Ganguly R. (1977). 'Therapeutic efficacy of inosiplex (Isoprinosine®) in rhinovirus infection', Annals of the New York Academy of Sciences, 284(1), 153-160.

Feldman S and Loft L. (1987). 'Varicella in children with cancer: impact of antiviral therapy and prophylaxis', Pediatrics, 80(4), 465-472.

Nakamura T, Miyasaka N, Pope R, Talal N and Russell I. (1983). 'Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases', Clinical and experimental immunology, 52(1), 67.

Krastev Z, Nikolova N, Jelev D, Antonov K and Mateva L. (2015). 'Inosine pranobex (Isoprinosine)–a potential adjuvant in the management of chronic HBV infection', MedInform, 2(1), 86-97.

Nikolova N, Antonov K, Mateva L and Krastev Z. (2014). 'Could Inosine pranobex and Ribavirin in combination restore immune competence in chronic HCV advanced liver disease?', MedInform, 1, 35-44.

Litzman J, Lokaj J, Krejčí M, Pešák S and Morgan G. (1999). 'Isoprinosine does not protect against frequent respiratory tract infections in childhood', European journal of pediatrics, 158(1), 32-37.

Bunn HF, May MH, Kocholaty WF and Shields CE. (1969). 'Hemoglobin function in stored blood', The Journal of clinical investigation, 48(2), 311-321.

Khakoo RA, Watson GW, Waldman RH and Ganguly R. (1981). 'Effect of inosiplex (Isoprinosine®) on induced human influenza A infection', Journal of Antimicrobial Chemotherapy, 7(4), 389-397.

Huttenlocher PR and Mattson RH. (1979). 'Isoprinosine in subacute sclerosing panencephalitis', Neurology, 29(6), 763-763.

Cianciara J, Laskus T, Gabinska E and Loch T. (1990). 'Isoprinosine in the treatment of chronic active hepatitis type B', Scandinavian journal of infectious diseases, 22(6), 645-648.

Pár A, Beró T, Brasch G, Gógl A, Kamarás G, Méhesfalvi E, Ozsvár Z, Paál M, Szipöcs I and Telegdy L. (1993). 'Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)', Orvosi hetilap, 134(19), 1015-1019.

Koupenova M and Ravid K. (2013). 'Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism', Journal of cellular physiology.

March J, Field J, Shanley J and Turner WJ. (1973). 'Biochemical observations during a trial of inosiplex in senile dementia', Journal of the American Geriatrics Society, 21(8), 372-378.

Bhandary BSK, Sharmila K, Kumari NS, Bhat VS and Fernandes R. (2017). 'Acute and Subacute Toxicity Profile of Asparagus racemosus root extract, Isoprinosine and Shatvari Syrup in Swiss Albino Mice', Journal of Applied Pharmaceutical Science Vol, 7(05), 129-135.